Category Laser Eye Surgery Boulder Colorado
Learn More About Eye Surgery, LASIK
Are you one of those poor people that can't seem to see as well as they used to. Are you near
sighted or far sighted? Perhaps you also have astigmatism? If this sounds like you, you may have
thought about LASIK eye surgery. LASIK stands for laser assisted in situ keratomileusis. LASIK eye
surgery is a procedure that permanently changes the shape of the cornea (the clear covering over
the front of the eye). Before you ask, yes it does use a laser! Before you decide on LASIK eye
surgery, you should get the facts on LASIK eye surgery.
First, before Click here to read the rest of this article ... This page is dedicated to providing you with the knowledge you need when considering laser eye surgery. This procedure can be a bit intimidating for people and hopefully you will feel much more comfortable about it once you have read this. A popular procedure is lasik eye surgery which is intended to reduce your dependency on either your eyeglasses or contact lenses. Your best bet to get fully informed before having laser eye surgery is to go for an evaluation with your optometrist to see if you are a potential candidate for laser vision correction. Before moving forward you want to ensure that you are fully informed about the procedure. Prior Click here to read the rest of this article ... |
Laser Eye Surgery Boulder Colorado News
Facts At Your Fingertips!
|
Alcon Sued for Products Liability Due to Recall of Defective LADAR6000 Excimer Laser (PRWeb) Jenna Reed and Rian Reed vs. Alcon Laboratories, Inc., Alcon Manufacturing, Ltd., and Alcon Refractive Horizons, Inc. United State District Court, District of Colorado. (PRWeb Aug 24, 2008) Read the full story at http://www.prweb.com/releases/2008/08/prweb1239814.htm Sun, 24 Aug 2008 07:14:02 GMT Quark Pharmaceuticals Announces First Patient Dosing By Pfizer In Phase II Trial Of RNAi Therapy In Diabetic Macular ... (Medical News Today) Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that its partner, Pfizer Inc, initiated patient dosing in a Phase II trial evaluating PF-4523655 (RTP801i-14) in patients with diabetic macular edema (DME). Thu, 31 Jul 2008 10:12:57 GMT
- InSight Lasik |
Where Knowledge is Power...
Read On!
![]() |
